Bupropion Use and Risk of Open-Angle Glaucoma among Enrollees in a Large U.S. Managed Care Network

OBJECTIVE: Tumor Necrosis Factor (TNF) mediates retinal ganglion cell death in glaucoma. Anti-TNF drugs are neuroprotective in an animal model of glaucoma. It is unclear whether medications with anti-TNF properties such as bupropion have an impact on the risk of developing open-angle glaucoma (OAG)...

Descripción completa

Detalles Bibliográficos
Autores principales: Stein, Joshua D., Talwar, Nidhi, Kang, Jae H., Okereke, Olivia I., Wiggs, Janey L., Pasquale, Louis R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395241/
https://www.ncbi.nlm.nih.gov/pubmed/25875446
http://dx.doi.org/10.1371/journal.pone.0123682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395241/
https://www.ncbi.nlm.nih.gov/pubmed/25875446
http://dx.doi.org/10.1371/journal.pone.0123682

Ejemplares similares